Notice to Encourage Eligible NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees to Apply for PA-20-222 "Research Supplements to Promote Diversity in Health-Related Research"
Notice Number:
NOT-NS-20-089

Key Dates

Release Date:

August 13, 2020

Related Announcements

PA-20-222 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

NOT-NS-19-003 - Rescinded

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

This notice replaces NOT-NS-19-003 "Notice to Encourage Eligible NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Initiative Awardees to Apply for PA-18-906 "Research Supplements to Promote Diversity in Health-Related Research".

This Notice encourages eligible NINDS awardees in the Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) research community to apply for administrative supplements in response to PA-20-222, "Research Supplements to Promote Diversity in Health-Related Research." The NIH has a strong interest in the diversity of the NIH-funded workforce (see NOT-OD-20-031 for details) and encourages institutions to diversify their student populations by enhancing the participation of individuals from groups that are underrepresented in the biomedical, clinical, behavioral, and social sciences. Goal 1 of The National Plan to Address Alzheimer’s Disease is to prevent and effectively treat AD/ADRD by 2025. This initiative addresses the critical need to increase the number of health professionals who are trained to meet the expanding demand for cognitive impairment and dementia diagnosis, care, and clinical research to meet Goal 1.

 Program Directors/Principal Investigators (PD/PI) of active AD/ADRD research grants are thus encouraged to consider administrative supplements under this program at the following career levels: high school students, undergraduate students, baccalaureate and master’s degree holders, graduate (predoctoral) and health professional students, individuals in postdoctoral training, and investigators developing independent research careers. All applications must include a signed statement from an institutional official establishing eligibility of the candidate for the program, including information about citizenship of the candidate and a description of how the candidate would further the goals of the program, consistent with the Notice of NIH's Interest in Diversity (NOT-OD-20-031). The activities proposed in the supplement application must fall within the scope and advance the objectives of the parent grant and support the research training and professional development of the supplement candidate. PIs must reference this Notice in the cover letter and application.

 Diversity supplement awardees, as appropriate for the duration of their support and career stage, may request funds, in addition to the research costs specified in PA-20-222, to enable the supplement candidate to attend the AD/ADRD research summits in the Washington, DC area. This request for additional funds should be reasonable and well justified in the application.

Applicants are strongly encouraged to consult with the Program Official for the parent grant or the contact listed below before submitting an application to confirm eligibility and to obtain technical assistance. Supplement requests under this Notice (and submitted to PA-20-222) will undergo administrative evaluation by NINDS staff, but not a full peer review. Eligible AD/ADRD research awards can be identified by using NIH RePORTER or by contacting Dr. Roderick Corriveau via email. For tracking, when a diversity supplement application responsive to this Notice is submitted please email Dr. Roderick Corriveau and include the PD/PI name and grant number in the subject line of the email.

Applications will be considered according to the following schedule:

Application Due Date                  Earliest Funding Decision
July 16, 2020 – October 15, 2020           November 2020

October 16, 2020 – January 15, 2021     February 2021

January 16, 2021 – April 15, 2021          May 2021

April 16, 2021 – July 15, 2021                August 2021

July 16, 2021 – October 15, 2021            November 2021

October 16, 2021 – January 15, 2022      February 2022

January 16, 2022 – April 15, 2022           May 2022

April 16, 2022 – July 15, 2022                  August 2022

July 16, 2022 – October 15, 2022            November 2022

October 16, 2022 – January 15, 2023       February 2023

January 16, 2023 – April 15, 2023            May 2023

Inquiries

Please direct all inquiries to:

Roderick Corriveau, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5680
Email: roderick.corriveau@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices